RXi Pharmaceuticals: Keeping A Large Focus On Shareholder Value Creation In 2016

RXi is expected to have multiple data readouts throughout all of 2016. This provides multiple catalysts opportunities for investors looking to buy shares of a company like RXi with a good risk/reward scenario.